Progenics Pharma (PGNX) Will Present 1404 and PyL Data at SNMMI 2016
Tweet Send to a Friend
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that data from its 1404 and PyL prostate cancer imaging programs will be ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
